Intelligence Platform
Patents
Browse 774 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8809377
Deubiquitinase inhibitors and methods for use of the same
granted patentUS 8809323
Therapeutic applications of pro-apoptotic benzodiazepines
granted patentUS 8796223
Methods of inhibiting photoreceptor apoptosis
granted patentUS 8795668
Methods for treating pulmonary fibrosis
granted patentUS 8791104
1,4-benzodiazepine-2,5-diones with therapeutic properties
granted patentUS 8790878
Diagnosis and treatment of breast cancer
granted patentUS 8781559
Method of evaluating metabolism of the eye
granted patentUS 8771731
Antimicrobial nanoemulsion compositions and methods
granted patentUS 8764828
System and method for forming bone, ligament, and bone-ligament constructs
granted patentUS 8768431
Systems and methods for tissue imaging
granted patentUS 8765671
Methods and compositions for modulation of blood-neural barrier
granted patentUS 8765168
Compositions of a fluorapatite and methods of use
granted patentUS 8759340
Benzodiazepinone compounds useful in the treatment of skin conditions
granted patentUS 8759327
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid
granted patentUS 8759301
Gene fusion targeted therapy
granted patentUS 8748385
Adult cerebellum-derived neural stem cells and compositions and methods for producing olig
granted patentUS 8747872
Nanoemulsion therapeutic compositions and methods of using the same
granted patentUS 8742121
Process for the preparation of small molecule inhibitors of MDM2 and intermediates used th
granted patentUS 8735538
Use of methanobactin
granted patentUS 8722667
Compositions and methods for inhibiting the proliferation of cells
granted patentUS 8709464
Porous objects having immobilized encapsulated biomolecules
granted patentUS 8697407
Compositions and methods for inhibiting MMSET
granted patentUS 8697081
Method of modulating neovascularization
granted patentUS 8691184
Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
granted